Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

230 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
Lee JS, Hur JY, Kim IA, Kim HJ, Choi CM, Lee JC, Kim WS, Lee KY. Lee JS, et al. Among authors: Choi CM. BMC Cancer. 2018 Dec 10;18(1):1236. doi: 10.1186/s12885-018-5138-3. BMC Cancer. 2018. PMID: 30526536 Free PMC article.
The relationship between the presence of chromosomal instability and prognosis of squamous cell carcinoma of the lung: fluorescence in situ hybridization analysis of paraffin-embedded tissue from 47 Korean patients.
Yoo JW, Seo KW, Jang SJ, Oh YM, Shim TS, Kim WS, Lee DS, Lee SD, Choi CM. Yoo JW, et al. Among authors: Choi CM. J Korean Med Sci. 2010 Jun;25(6):863-7. doi: 10.3346/jkms.2010.25.6.863. Epub 2010 May 24. J Korean Med Sci. 2010. PMID: 20514306 Free PMC article.
Combined treatment with silibinin and epidermal growth factor receptor tyrosine kinase inhibitors overcomes drug resistance caused by T790M mutation.
Rho JK, Choi YJ, Jeon BS, Choi SJ, Cheon GJ, Woo SK, Kim HR, Kim CH, Choi CM, Lee JC. Rho JK, et al. Among authors: Choi YJ, Choi SJ, Choi CM. Mol Cancer Ther. 2010 Dec;9(12):3233-43. doi: 10.1158/1535-7163.MCT-10-0625. Mol Cancer Ther. 2010. PMID: 21159609
FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapy.
Yoon DH, Baek S, Choi CM, Lee DH, Suh C, Ryu JS, Moon DH, Lee JS, Kim SW. Yoon DH, et al. Among authors: Choi CM. Clin Cancer Res. 2011 Aug 1;17(15):5093-100. doi: 10.1158/1078-0432.CCR-10-2791. Epub 2011 Jun 14. Clin Cancer Res. 2011. PMID: 21673067 Clinical Trial.
Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.
Choi CM, Jang SJ, Park SY, Choi YB, Jeong JH, Kim DS, Kim HK, Park KS, Nam BH, Kim HR; Korean Thoracic Oncology Research Group (KTORG), Kim SY, Hong KM. Choi CM, et al. Among authors: Choi YB. Mol Cancer. 2011 Sep 24;10:119. doi: 10.1186/1476-4598-10-119. Mol Cancer. 2011. PMID: 21943122 Free PMC article.
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma.
Paik JH, Choi CM, Kim H, Jang SJ, Choe G, Kim DK, Kim HJ, Yoon H, Lee CT, Jheon S, Choe JY, Chung JH. Paik JH, et al. Among authors: Choi CM. Lung Cancer. 2012 Jun;76(3):403-9. doi: 10.1016/j.lungcan.2011.11.008. Epub 2011 Nov 30. Lung Cancer. 2012. PMID: 22129856
230 results
Jump to page
Feedback